Qualcomm Responds to Elliott Regarding NXP
Get Alerts QCOM Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.2%
EPS Growth %: -25.7%
Join SI Premium – FREE
SAN DIEGO, Dec. 11, 2017 /PRNewswire/ -- Qualcomm Incorporated (NASDAQ: QCOM) today issued the following statement in response to Elliott Management regarding NXP.
Elliott's value assertion for NXP is unsupportable and is clearly nothing more than an attempt to advance its own self-serving agenda. We remain fully committed to closing the acquisition of NXP and believe that the agreed-upon price of $110 is full and fair.
About Qualcomm
Qualcomm's technologies powered the smartphone revolution and connected billions of people. We pioneered 3G and 4G – and now we are leading the way to 5G and a new era of intelligent, connected devices. Our products are revolutionizing industries, including automotive, computing, IoT, healthcare and data center, and are allowing millions of devices to connect with each other in ways never before imagined. Qualcomm Incorporated includes our licensing business, QTL, and the vast majority of our patent portfolio. Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, all of our engineering, research and development functions, and all of our products and services businesses, including, our QCT semiconductor business. For more information, visit Qualcomm's website, OnQ blog, Twitter and Facebook pages.
Qualcomm Contacts:Pete Lancia, Corporate CommunicationsPhone: 1-858-845-5959Email: [email protected]
John Sinnott, Investor RelationsPhone: 1-858-658-4813Email: [email protected]
View original content:http://www.prnewswire.com/news-releases/qualcomm-responds-to-elliott-regarding-nxp-300569542.html
SOURCE Qualcomm Incorporated
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Union Pacific CFO Jennifer Hamann to retire in early 2027
- New Progress -- XellSmart Unveiled Phase I Results of Off-the-Shelf Parkinson's Disease Cell Therapy at MDS & Completed Blinded Phase II Enrollment
- XRP Price Prediction: A $10 XRP Would Mean a $630B Valuation, but Could AlphaPepe Make Smaller Buyers Bigger Winners?
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Elliott Associates, Twitter, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share